BLOG

How Are NK Cells Expanded for Therapy? What to Ask in Osaka

Published 2026.10.17 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are considering NK cell therapy, one of the first questions is often practical: what actually happens to your cells between the blood draw and the infusion? The step in the middle, where NK cells are activated and expanded outside the body, is the least visible part of the treatment, yet it is where many of the quality questions sit. This article explains the process in plain language so you can ask better questions at a consultation at Grand Green Osaka Umekita Clinic or any other clinic you are comparing.

The short answer: your own cells are activated and expanded, then returned

NK (natural killer) cells are innate immune cells that patrol the body and can recognize and attack cancer cells and virus-infected cells without waiting for instructions from other immune cells. NK cell activity is thought to decline with age, stress and the effects of cancer itself. In NK cell therapy, NK cells are taken from a standard blood draw, activated and expanded at a specialized cell processing facility, and then returned to your body by intravenous infusion. The aim is to give the immune system a larger number of more active NK cells to work with.

It is important to be realistic about what this means. NK cell therapy is a cancer immune cell therapy that is considered alongside standard treatment, not a replacement for it, and it cannot be promised to produce any particular result. Whether it is appropriate for you is a decision that requires a doctor’s examination.

Step by step: from blood draw to infusion

The process can be understood as a sequence of stages. Exact details differ between facilities, so treat the following as a general outline and confirm the specifics with your doctor.

A blood sample is collected in the clinic, in a way similar to an ordinary blood test.
The sample is sent to a licensed cell processing facility, where NK cells are separated from other blood components.
The NK cells are cultured with specific stimulating factors so that their number increases and their activity is enhanced.
The cultured cells are tested and checked against quality criteria set by the facility before release.
The cells are returned to you by intravenous infusion at the clinic, usually without a hospital stay.

Because the treatment uses your own cells, the risk of rejection is considered low, and serious side effects have rarely been reported. Temporary fever or fatigue can still occur, so it is reasonable to ask what monitoring is provided and what to do if symptoms appear after an infusion.

Why the culture step deserves attention

Culturing living cells is a technical process. The number of cells obtained, how active they are and whether the culture is free from contamination can all depend on the facility, its procedures and the condition of your own blood sample. For this reason, the quality management of the cell processing facility is a meaningful topic for patients to ask about, rather than a background detail.

It also helps to understand that results of cell expansion can vary from person to person. Patients who have received intensive chemotherapy or who have a reduced blood cell count may yield different amounts of usable cells. A responsible clinic will explain these limits and will not describe the culture step as a guaranteed or uniform process.

How Japanese regulation relates to cell processing

In Japan, cell therapies of this kind are provided under the Act on the Safety of Regenerative Medicine. Under this framework, a clinic submits a regenerative medicine provision plan, which is reviewed by a certified committee and then accepted by the Ministry of Health, Labour and Welfare. Cell processing is expected to take place at a facility that is licensed or notified under the same system. This structure is intended to support safety management, but it does not remove the need for individual medical judgment.

NK cell therapy is offered as a self-pay treatment, which means it is not covered by public health insurance. Costs, the number of infusions, the treatment period, risks and side effects should all be confirmed in a consultation before you decide.

Questions worth asking before you start

A list of concrete questions can make a first consultation more productive. Consider bringing the following to your doctor.

Where are my cells processed, and under what legal framework is the facility operating?
How is the quality of the cultured cells checked before they are returned to me?
What happens if the culture does not yield enough cells?
How many infusions are usually planned, over what period, and what is the total cost?
How would this treatment be coordinated with my surgery, chemotherapy or radiation therapy, and can my current oncologist be contacted?
What temporary reactions should I expect, and whom should I contact if I feel unwell afterwards?
What does the available evidence say, and what remains uncertain?

Published research on NK cell therapy is still developing, and findings from individual studies should not be generalized too far. A good clinic will welcome these questions and will be open about the limits of current knowledge.

Consulting in Osaka as an international patient

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka and provides an information page for foreign patients, so that people who do not read Japanese can review the flow of treatment, fees and frequently asked questions before contacting the clinic. If you are traveling for treatment, it is worth discussing how your visits would be scheduled around your travel plans and your home-country care team. Bringing a summary of your diagnosis and current treatment from your own doctor can help the consultation go more smoothly.

This article is general information and is not a substitute for medical advice. Please review the treatment page for fees, the number of sessions, risks and side effects, and speak with a physician about whether NK cell therapy fits your situation.

From blood draw to infusion

1Blood drawStandard blood sample
2Activation and expansionAt a cell processing facility
3Quality checkBefore release
4IV infusionReturned at the clinic

This figure is a conceptual diagram that summarizes the article

Learn more about NK Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›